SCHEMBL6404017

SCHEMBL6404017

CC(C)(C)CCc1nnc(-c2ccccc2)o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
NOTUM Q6P988 2/20 0.57
LMNA P02545 1/20 0.57
RAB9A P51151 6/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
NPC1 O15118 4/20 0.56
HPGD P15428 2/20 0.56
TSHR P16473 1/20 0.56
GPR55 Q9Y2T6 1/20 0.56
POLB P06746 4/20 0.52
TP53 P04637 1/20 0.52
KMT2A Q03164 3/20 0.50
NR1H4 Q96RI1 1/20 0.50
MEN1 O00255 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MAPT P10636 1/20 0.49
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
ATM Q13315 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6405143 0.86 ALDH1A1 (0.53) ALDH1A1NOTUMLMNARAB9ASMN1; SMN2
SCHEMBL6605152 0.84 POLB (0.63) NOTUMLMNARAB9ASMN1; SMN2NPC1
SCHEMBL19798382 0.83 ALDH1A1 (0.61) ALDH1A1NOTUMLMNARAB9ASMN1; SMN2
SCHEMBL6605688 0.81 NR1H4 (0.52) ALDH1A1NOTUMRAB9ASMN1; SMN2NPC1
SCHEMBL21303556 0.81 MAPT (0.66) ALDH1A1NOTUMLMNARAB9ASMN1; SMN2
SCHEMBL3863062 0.78 ALDH1A1 (0.59) ALDH1A1NOTUMLMNARAB9ASMN1; SMN2
SCHEMBL13731090 0.77 RAB9A (0.71) ALDH1A1NOTUMLMNARAB9ASMN1; SMN2
SCHEMBL7976958 0.77 ALDH1A1 (0.62) ALDH1A1NOTUMLMNARAB9ASMN1; SMN2
SCHEMBL29291257 0.77 ALDH1A1 (0.62) ALDH1A1NOTUMLMNARAB9ASMN1; SMN2
SCHEMBL28295593 0.77 ALDH1A1 (0.73) ALDH1A1NOTUMLMNARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107616-A1 Alpha-ketoamide derivatives as cathepsin k inhibitors SMITHKLINE BEECHAM CORPORATION 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107616-A1 Alpha-ketoamide derivatives as cathepsin k inhibitors CTSK, CTSE, CTSZ ALDH1A1 2900/4885NOTUM 1001/4885LMNA 736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.